CYTOSORBENTS CORPORATION (CTSO) Net income 2016–2025
CYTOSORBENTS CORPORATION (CTSO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.2MFY2025 · since FY2016: -$11.8M → -$8.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.2M | +60.4% |
| FY2024 | -$20.7M | +29.2% |
| FY2023 | -$29.2M | +10.9% |
| FY2022 | -$32.8M | -33.6% |
| FY2021 | -$24.6M | -213.4% |
| FY2020 | -$7.8M | +59.3% |
| FY2019 | -$19.3M | -11.9% |
| FY2018 | -$17.2M | -103.4% |
| FY2017 | -$8.5M | +28.1% |
| FY2016 | -$11.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice